Pamidronate disodium salt
 OpenBabel02212023462D

 15 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Na  0  3  0  0  0 15  0  0  0  0  0  0
    1.0018    0.0000    0.0000 Na  0  3  0  0  0 15  0  0  0  0  0  0
   -0.8514   -1.6500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2681   -2.2334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4816   -3.0303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1018   -3.6136    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6851   -4.1970    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4816   -4.1970    0.0000 P   0  0  3  0  0  0  0  0  0  0  0  0
   -1.0650   -3.6136    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1018   -4.7803    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
   -1.0650   -4.7803    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6851   -3.0303    0.0000 P   0  0  3  0  0  0  0  0  0  0  0  0
    1.2685   -3.6136    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1018   -2.4469    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
    1.2685   -2.4469    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6 12  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
  8 11  2  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 12 15  2  0  0  0  0
M  CHG  4   1   1   2   1  10  -1  14  -1
M  END
>  <CdId>
770

>  <Mol Weight>
279.0331

>  <Formula>
C3H9NNa2O7P2

>  <ID>
T1337

>  <Name>
Pamidronate disodium salt

>  <Synonyms>
CGP 23339A

>  <CAS>
57248-88-1

>  <Approved status>
FDA

>  <Disease>
Cancer

>  <Indication>
Cancer Metastases; Malignant Hypercalcaemia; Osteitis Deformans; Osteogenesis Imperfecta; Osteoporosis; Postmenopausal Osteoporosis

>  <Pathways>
Microbiology&Virology; Others

>  <Target>
HBV; Others

>  <Receptor>
HAP; FPPS

$$$$
